These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15611972)

  • 21. An acute-leukaemia-like picture due to breast carcinoma cells.
    Pitini V; Arrigo C; Altavilla G
    Lancet Oncol; 2006 Jun; 7(6):524. PubMed ID: 16750505
    [No Abstract]   [Full Text] [Related]  

  • 22. [Breast neoplasms: micrometastasis].
    Kosaka Y; Mimori K; Mori M; Moriyama N; Watanabe M
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():47-53. PubMed ID: 17682138
    [No Abstract]   [Full Text] [Related]  

  • 23. Minimal residual disease and circulating tumor cells in breast cancer: open questions for research.
    Ignatiadis M; Sotiriou C; Pantel K
    Recent Results Cancer Res; 2012; 195():3-9. PubMed ID: 22527490
    [No Abstract]   [Full Text] [Related]  

  • 24. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastasis of the breast carcinoma to the adrenocortical adenoma.
    Scierski A; Podworski H
    Arch Geschwulstforsch; 1973; 42(3):240-3. PubMed ID: 4784635
    [No Abstract]   [Full Text] [Related]  

  • 26. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating epithelial cells in breast cancer.
    Tang C; Lin AY
    N Engl J Med; 2004 Dec; 351(23):2452-4; author reply 2452-4. PubMed ID: 15580681
    [No Abstract]   [Full Text] [Related]  

  • 28. The differential diagnosis of dyspnea in a woman with metastatic breast cancer--consideration beyond pulmonary embolism.
    Dizon DS; Beheshti J; McDonough K; Gass J
    Breast J; 2008; 14(1):90-1. PubMed ID: 18186870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in the bone marrow of patients with breast cancer.
    Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
    Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
    Vincent-Salomon A; Caly M; De Rycke Y; Fréneaux P; Klijanienko J; Laé M; Viard F; Nos C; Bidard FC; Alran S; Salmon R; Kirova Y; Pierga JY; Sigal-Zafrani B; Sastre-Garau X
    Eur J Cancer; 2009 Jul; 45(11):1979-86. PubMed ID: 19375305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the way to specifically targeting minimal residual disease?
    Gebauer G
    Breast Cancer Res; 2008; 10(5):112. PubMed ID: 18947365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells in patients with breast cancer dormancy.
    Meng S; Tripathy D; Frenkel EP; Shete S; Naftalis EZ; Huth JF; Beitsch PD; Leitch M; Hoover S; Euhus D; Haley B; Morrison L; Fleming TP; Herlyn D; Terstappen LW; Fehm T; Tucker TF; Lane N; Wang J; Uhr JW
    Clin Cancer Res; 2004 Dec; 10(24):8152-62. PubMed ID: 15623589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Breast cancer].
    Ataseven B; Eiermann W
    Dtsch Med Wochenschr; 2006 May; 131(19):1091-9; quiz 1101-2. PubMed ID: 16685631
    [No Abstract]   [Full Text] [Related]  

  • 35. [Deliberations on the growth dynamics of mamacarcinoma as based on the mitosis index].
    Regele H
    Wien Klin Wochenschr; 1968 May; 80(22):436-8. PubMed ID: 5701106
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone marrow isolated micrometastases of non-small cell lung cancer].
    Dancewicz M; Kowalewski J; Sir J; Pepliński J; Jezierska A
    Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
    Masuda TA; Kataoka A; Ohno S; Murakami S; Mimori K; Utsunomiya T; Inoue H; Tsutsui S; Kinoshita J; Masuda N; Moriyama N; Mori M
    Int J Oncol; 2005 Mar; 26(3):721-30. PubMed ID: 15703829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
    Klein CA
    Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.